Validation of a GC-MS screening method for anabolizing agents in aqueous nutritional supplements

Journal of Chromatographic Science

Volumn 43, Issue 1, 2005, Pages 2-6

  Van Thuyne, W ^a   Delbeke, F T ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

19 HYDROXYANDROSTENEDIONE; 19 NOR 4 ANDROSTENE 3,17 DIOL; 19 NOR 4(5) ANDROSTENE 3,17 DIONE; 3BETA ANDROSTANEDIOL; 4 ANDROSTENE 3BETA 17BETA DIOL; 4(5) ANDROSTENE 3,17 DIONE; 5 ALPHA ANDROSTANE 3ALPHA,17BETA DIOL; 5 ANDROSTENE 3BETA 17BETA DIOL; 7 KETO DEHYDROEPIANDROSTERONE; ACETAMIDE DERIVATIVE; ANABOLIC AGENT; BOLDENONE; CLENBUTEROL; CREATINE; ETHER; METANDIENONE; METHYLTESTOSTERONE; N METHYL N TRIMETHYLSILYLTRIFLUOROACETAMIDE; NANDROLONE; NANDROLONE DECANOATE; NANDROLONE LAURATE; NANDROLONE PHENPROPIONATE; PENTANE; PRASTERONE; STANOZOLOL; TESTOSTERONE; TESTOSTERONE DECANOATE; TESTOSTERONE ISOCAPROATE; TESTOSTERONE PHENYLPROPIONATE; TESTOSTERONE PROPIONATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

ARTICLE; CREATINE KINASE BLOOD LEVEL; DERIVATIZATION; DIET SUPPLEMENTATION; GAS CHROMATOGRAPHY; ION MONITORING; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; SCREENING; SERUM; SOLID; URINALYSIS; URINE;

EID: 12844286026     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/43.1.2     Document Type: Article

References (17)

1. U. Schröder. "Health effects of nutritional supplements". In Health and Doping Risks of Nutritional Supplements and Social Drugs. W. Schänzer, F.T. Delbeke, A. Deligiannis, G. Gmeiner, R. Maughan, and J. Mester, Eds. Sport & Buch Strauss, Köln, Germany, 2002.
2. R.J. Maughan, D.S. King, and T. Lea. Dietary supplements. J. Sports Sci. 22: 95-113 (2004).
3. R. Maughan. "The scope of nutritional supplements in sport". In Health and Doping Risks of Nutritional Supplements and Social Drugs. W. Schänzer, F.T. Delbeke, A. Deligiannis, G. Gmeiner, R. Maughan, and J. Mester, Eds. Sport & Buch Strauss, Köln, Germany, 2002.
4. United States Congress. Dietary Supplement Health and Education Act of 1994. Pub L No. 103-417, 103rd Congress, 2nd sess, S784. Washington, D.C., 1994.
5. International Olympic Committee. List of prohibited classes of substances and methods of doping. International Olympic Committee, Medical Commission, Lausanne, Switzerland, 2001.
6. C.E. Broeder, J. Quindry, K. Brittingham, L. Panton, J. Thomson, S. Appakondu, K. Breuel, R. Byrd, J. Douglas, C. Earnest, C. Mitchell, M. Olson, T. Roy, and C. Yarlagadda. The andro project: the physiological and hormonal influences of androstenedion supplementation in men 35 to 65 years old participating in high intensity resistance training program. Arch. Intern. Med. 160: 3093-3104 (2000).
7. D.S. King, R.L. Sharp, M.D. Vukovich, G.A. Brown, T.A. Reifenrath, N.L. Uhl, and K.A. Parsons. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomised controlled trial. JAMA 281(21): 2020-28 (1999).
8. B.Z. Leder, C. Longcope, D.H. Catlin, B. Ahrens, D.A. Schoenfeld, and J.S. Finkelstein. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA 283: 779-82 (2000).
9. H. Geyer, U. Mareck-Engelke, U. Reinhart, M. Thevis, and W. Schänzer. Positive dopingfälle mit norandrosteron durch verunreinigte nahrungsergänzungsmittel. Dtsch. Z. Sportmed. 51(11): 378-82 (2000).
10. H. Geyer, U. Mareck-Engelke, A. Wagner, and W. Schänzer. "The analysis of "non-hormonal" nutritional supplements for prohormones". In Recent Advances in Doping Analysis (9). W. Schänzer, A. Gotzmann, and U. Mareck-Engelke, Eds. Sport & Buch Strauss, Koln, Germany, 2001, pp. 63-71.
11. K.J.S. De Cock, F.T. Delbeke, P. Van Eenoo, N. Desmet, K. Roels, and P. De Backer. Detection and determination of anabolic steroids in nutritional supplements. J. Pharm. Biomed. Anal. 25: 843-52 (2001).
12. H. Geyer, M.K. Parr, U. Reinhart, Y. Schrader, U. Mareck, and W. Schänzer. "Analysis of non-hormonal nutritional supplements for anabolic androgenic steroids - an international study". In Recent Advances in Doping Analysis (10). W. Schänzer, H. Geyer, A. Gotzman, U. Mareck, Eds. Sport und Buch Strauss, Koln, Germany, 2002, pp. 83-85.
13. G. Gmeiner. Methandienon in sportnahrung. Oster. J. Sportmed. 2: 33-34 (2002).
14. H. Geyer, M. Bredehöft, U. Mareck, M.K. Parr, and W. Schänzer. Hoge dosen des anabolikums metandienon in nahrungsergänzungsmittel. Dtsch. Apoth. Ztg. 142(29): 50 (2002).
15. W. Van Thuyne and F.T. Delbeke. Validation of a GC-MS screening method for anabolizing agents in solid nutritional supplements. Biomed. Chromatogr. 18(3): 155-59 (2004).
16. Eurachem. "The fitness for purpose of analytical methods". In A Laboratory Guide to Method Validation and Related Topics, Vol. 61. LGC Ltd., Teddington, U.K., 1998, pp. 1-61.
17. W. Verwaal, M. van Bavel, A. Boot, J. Bravenboer. F. de Goei, C. Maas, and A. van der Putten. Valideren van (fysisch-) chemische en (fysisch-) mechanische methoden op het niveau van de wettelijke eis. De Ware(n) Chemicus 26: 25 (1996).